Kocitaf Tablet

2,199.00

50% Off
Close
Price Summary
  • 4,390.00
  • 2,199.00
  • 50%
  • 2,199.00
  • Overall you save 2,191.00 (50%) on this product
In Stock
Highlights:

Buy Kocitaf Tablet Only @2199 Hivhub

Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir Alafenamide (25mg)

  • “Buy More Gete More Benefite”
Compare
Description

Last Updated on January 10, 2024 by admin

Buy Kocitaf Tablet Online

About Kocitaf Tablet

Salt: Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir Alafenamide (25mg)

Kocitaf Tablet INTRODUCTION

Kocitaf Tablet is a combination of antiretrovirals medicines. It is prescribed to treat HIV (human immunodeficiency virus) infection. It boosts up the immunity to fight against HIV to manage or treat AIDS (acquired immunodeficiency syndrome).

Kocitaf Tablet restricts the growth of HIV in the body and reduces the risk of getting HIV-related complications to improve the lifespan of an individual. The medicine can be taken with or without food. Taking these Kocitaf Tablet regularly at the same time increases their effectiveness. A dose of this Kocitaf Tablet should not be missed as it can affect your recovery. It is important to complete the full course of the treatment until your doctor advises you to stop it. Sudden discontinuation of the treatment may affect the potency of the medicine.

The most common side effects of this Kocitaf Tablet are insomnia, fatigue, headache, and nausea. These side effects are generally temporary, but if they persist or become serious inform your doctor. This medicine can also make you feel lazy or weak, so it is advised to avoid driving. Drinking plenty of fluid can help you to cope up with the side effects, so stay hydrated.

Before starting with the treatment, you should consult your doctor if you are pregnant or breastfeeding, or have any health condition. Your doctor may suggest regular blood tests to check your blood counts, kidney and liver functions, and other health conditions. If you are HIV positive, you should not breastfeed or share personal belongings like razors or toothbrushes. Consult your doctor to know about safe sex methods in order to prevent transmission of HIV during intercourse.

USES OF Kocitaf TABLET

The Dolutegravir (50mg) Emtricitabine (200mg) Tenofovir Alafenamide (25mg) TABLET (Kocitaf Tablet) is primarily used for the treatment of HIV-1 infection in adults and adolescents weighing at least 40kg. It is not a cure for HIV, but it helps control the virus and reduces the risk of complications associated with the infection.

Kocitaf Tablet: Directions for Use

It is crucial to follow the prescribed dosage and instructions provided by your healthcare professional. The Kocitaf Tablet is typically taken once daily with or without food. Swallow the tablet whole with a glass of water. Do not crush, chew, or break the tablet unless instructed otherwise by your doctor.

BENEFITS OF Kocitaf TABLET

Kocitaf Tablet prevents HIV from multiplying in the body. It helps control the infection and make the immune system work better. This lowers the chances of getting complications, such as new infections, and improves the quality of life. This Kocitaf Tablet is always taken in combination with other antiretroviral medicines.

It is not a cure of HIV or AIDS and should not be used to prevent HIV after accidental exposure to a risk. It is important to take this Kocitaf Tablet as prescribed by the doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of this combination of Kocitaf Tablet and reduces the chances of HIV infection becoming resistant to antiretroviral medicines. Although taking this medicine does not prevent the passing of HIV to other people.

Kocitaf Tablet: Storage

Store the Kocitaf Tablet at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets. Do not use the medication after the expiration date mentioned on the packaging.

Kocitaf Tablet: Medicinal Benefits

This combination medication (Kocitaf Tablet) offers several medicinal benefits for individuals living with HIV-1 infection:

  • Reduces the viral load in the body
  • Increases CD4 cell count, strengthening the immune system
  • Helps prevent the transmission of HIV to others
  • Improves overall health and quality of life

Kocitaf: Drug Warnings

Before starting this medication, inform your doctor about any existing medical conditions, allergies, or medications you are currently taking. It is essential to disclose your complete medical history to ensure the safe use of the Kocitaf Tablet.

Kocitaf: Drug Interactions

The Dolutegravir (50mg) Emtricitabine (200mg) Tenofovir Alafenamide (25mg) TABLET (Kocitaf Tablet) may interact with certain medications, including:

  • Antacids containing aluminum, magnesium, or calcium
  • Rifampin
  • Carbamazepine
  • Phenytoin
  • St. John’s wort

Inform your healthcare professional about all the medications you are taking to avoid any potential drug interactions.

Kocitaf Tablet: Drug Interactions Checker List: Safety Advice

It is important to consult your healthcare professional or use a reliable drug-drug interactions checker to ensure the safe use of the Dolutegravir (50mg) Emtricitabine (200mg) Tenofovir Alafenamide (25mg) TABLET (Kocitaf Tablet). They can provide you with personalized advice based on your specific medical history and medication regimen.

SIDE EFFECTS OF Kocitaf TABLET

Most side effects do not require any medical attention and disappear as your body adjusts to the Kocitaf Tablet. Consult your doctor if they persist or if you’re worried about them

Common side effects of Kocitaf

  • Insomnia (difficulty in sleeping)
  • Headache
  • Nausea
  • Fatigue

Severe side effects of Kocitaf

  • Renal impairment
  • Liver toxicity
  • Hypersensitivity
  • Worsening of hepatitis B (viral infection of liver)
  • Immune reconstitution syndrome
  • Lactic acidosis
  • Hepatomegaly (enlarged liver)
  • Anxiety

When Kocitafnot to use?

  • Allergy
    Kocitaf Tablet is not recommended for use in patients with a known allergy to dolutegravir, emtricitabine, tenofovir alafenamide, or any other inactive ingredients present in the formulation.
  • Dofetilide
    Kocitaf Tablet is not recommended for use in patients receiving dofetilide as it may increase the undesired effects of dofetilide which may lead to potentially serious and life-threatening side effects.

HOW TO USE Kocitaf TABLET

Take this Kocitaf Tablet in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Kocitaf Tablet may be taken with or without food, but it is better to take it at a fixed time.

HOW Kocitaf TABLET WORKS

Kocitaf Tablet is a combination of three medicines: Dolutegravir, Emtricitabine and Tenofovir Alafenamide. It is an anti-HIV medication and works by preventing the action of reverse transcriptase enzyme. This enzyme is responsible for production of HIV.

Kocitaf Tablet: Dosage

  • Missed Dose
    Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra Kocitaf Tablet to make up for the missed dose.
  • Overdose
    Seek emergency medical treatment or contact the doctor in case of an overdose.

General warnings

  • Lactic acidosis
    Kocitaf Tablet should be used with caution due to the increased risk of lactic acidosis. Report any unusual symptoms to the doctor on priority. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.
  • Decreased bone mineral density
    Kocitaf Tablet should be used with caution due to the increased risk of decreased bone mineral density. Report any unusual symptoms to the doctor on priority. Close monitoring of bone mineral density, appropriate corrective measures, and dose adjustments may be required in some cases based on the clinical condition
  • Immune reconstitution syndrome
    Kocitaf Tablet should be used with caution due to the increased risk of Immune reconstitution syndrome. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
  • Hypersensitivity reactions
    Kocitaf Tablet may cause severe allergic reactions such as skin rash, organ dysfunction, liver injury, etc. in some patients on therapy. Appropriate corrective measures, dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
  • Fat redistribution
    Kocitaf  Tablet may cause fat gain or fat loss from the body. This may result in peripheral wasting, facial wasting, breast enlargement, and Cushingoid appearance. Close monitoring of body weight and body fat distribution is necessary while receiving this medicine. Any changes in the body should be informed to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
  • Opportunistic infections
    The patients receiving Kocitaf Tablet may develop opportunistic infections such as pneumonia, herpes virus infections, etc. Report any unusual symptoms to the doctor immediately. Appropriate patient/caregiver education, corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

SAFETY ADVICE

warnings

alcohol warning   Alcohol

Caution is advised when consuming alcohol with Kocitaf Tablet. Please consult your doctor.

warnings

Pregnancy care   Pregnancy

SAFE IF PRESCRIBED

Kocitaf Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

warnings

   Breastfeeding

CONSULT YOUR DOCTOR

Information regarding the use of Kocitaf Tablet during breastfeeding is not available. Please consult your doctor.

warnings

   Driving

CONSULT YOUR DOCTOR

It is not known whether Kocitaf Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

warnings

   Kidney

UNSAFE

Kocitaf Tablet is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.

warnings

   Liver

UNSAFE

Kocitaf Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.

warning

baby warning  CHILDREN
UNSAFE
Kocitaf Tablet is not recommended for use in children and adolescents below 18 years.

  Kocitaf Tablet Habit Forming:

Dolutegravir (50mg) Emtricitabine (200mg) Tenofovir Alafenamide (25mg) TABLET (Kocitaf Tablet) is not habit-forming. It is a prescription medication that should only be used under the guidance of a healthcare professional.

   expert advice

  • Kocitaf Tablet is given to slow the progress of HIV infection.
  • Although treatment with Kocitaf Tablet can reduce the risk of you passing HIV to others through sexual contact, it does not stop it. It is therefore important to use condoms.
  • If you develop any infection soon after taking Kocitaf Tablet, inform your doctor. As a result of taking Kocitaf Tablet, your immune system may start fighting an infection that was present before you started the treatment, but you might not be aware of.
  • It may cause weakening of your bones. Exercise regularly and take calcium and vitamin D supplements as suggested by your doctor.
  • It is common for people with HIV to feel low or even depressed, especially soon after the diagnosis has been made.
  • If you have any feelings of depression it is advisable to speak with your doctor.

   FOOD AND DRINK

  • Eat a healthy and balanced diet. Eat vitamin and nutrient-rich food such as dark-green, yellow, orange, and red vegetables and fruit as it helps to boost your immune system. Option for lean protein and whole grains.
  • Avoid eating raw meat and eggs. Consume properly boiled and cooked meat, poultry, or seafood.
  • Eat bland and low-fat foods and avoid spicy or oily foods if you experience nausea or vomiting.
  • Try to reduce emotional and physical stress by spending time with family or whatever makes you happy.
  • Drink more fluids and avoid alcoholic beverages to prevent dehydration.
    Wash your hands properly before and after eating.
  • Make sure you sleep at least 8 hours a day.

FAQs ABOUT Kocitaf TABLET

Q: Does Kocitaf Tablet cure HIV infection?

A: Kocitaf Tablet does not completely cure HIV infection. While taking this medicine, you may still develop infections or other diseases associated with HIV infection. Consult your doctor for advice.

Q: Is Kocitaf Tablet safe in pregnancy?

A: Before taking Kocitaf Tablet, inform your doctor if you are pregnant, think you may be pregnant or are planning to get pregnant because it may harm your unborn baby. Consult your doctor before taking Kocitaf Tablet.

Q: Can Kocitaf TABLET be used on children?

A: Your doctor will prescribe the right dose depends on your child’s age, body weight and disease condition. Consult your doctor before taking Kocitaf Tablet.

Q: What if I miss a dose of Kocitaf TABLET?

A: If you miss a dose of Kocitaf Tablet, take it as soon as you remember. However, omit the missed dose if it is almost time for the next dose. Do not take Kocitaf Tablet twice to make up for a forgotten dose.

Q: Can I stop taking Kocitaf TABLET?

A: Do not stop taking Kocitaf Tablet without consulting your doctor. If you have any more doubts regarding the use of Kocitaf Tablet, ask your doctor.

Q: what is Kocitaf tablet price in india?

A: MRP of Kocitaf tablet is 4388.5, but 30 tablet bottle is available up to 2670/- with free shipping and cash on delivery Service available from hivhub.in.

Q: What is the effect of Kocitaf Tablet?

A: Kocitaf Tablet is used to treat HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better.

Q: What are the possible side effects of Kocitaf Tablet?

A: Common side effects of Kocitaf Tablet may include headache, nausea, diarrhea, and tiredness. However, not everyone experiences these side effects.

Q: What are the uses of Kocitaf Tablet?

A: Kocitaf Tablet is used in the treatment of HIV infection and as a part of post-exposure prophylaxis (PEP) to prevent HIV infection after potential exposure.

Q: Are there any alternative medications to Kocitaf Tablet?

A: Yes, there are alternative medications available for the treatment of HIV infection. It is important to consult with your healthcare provider to determine the most suitable option for you.

Q: What is the composition of Kocitaf Tablet?

A: Kocitaf Tablet contains a combination of three antiretroviral drugs – Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir Alafenamide (25mg), which work together to combat HIV infection.

Q: How is Kocitaf Tablet used for PEP (post-exposure prophylaxis)?

A: Kocitaf Tablet is used in combination with other medications as a part of PEP to prevent HIV infection after potential exposure, such as through unprotected sex or needle sharing.

Q: Can Kocitaf Tablet be used for the treatment of HIV infection?

A: Yes, Kocitaf Tablet is indicated for the treatment of HIV infection in adults and children weighing at least 30 kg.

Q: What is the role of Kocitaf Tablet in managing HIV infection?

A: Kocitaf Tablet helps to control and manage HIV infection by reducing the amount of virus in the body, allowing the immune system to function more effectively.

Q: Are there any specific considerations for using Kocitaf Tablet in HIV treatment?

A: It is important to take Kocitaf Tablet exactly as prescribed by your healthcare provider and to follow their instructions for monitoring and managing your HIV treatment.

Q: How does Kocitaf Tablet compare to other HIV medications?

A: Kocitaf Tablet offers the convenience of a fixed-dose combination of Dolutegravir and Lamivudine, which may simplify treatment regimens for some individuals. However, the choice of HIV medication should be made in consultation with a healthcare provider based on individual needs and circumstances.

I hope this FAQ helps provide valuable information about Kocitaf Tablet. If you have any further questions, feel free to ask at hivhub.in

References:

  1. Dolutegravir – DrugBank [Internet]. Drugbank.ca. 2018 [cited 26 December 2018]. Available from:
    https://www.drugbank.ca/drugs/DB08930
  2. Dolutegravir: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2019 [cited 27 March 2019]. Available from:
    https://medlineplus.gov/druginfo/meds/a613043.html
  3. Emtricitabine: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 21 March 2018]. Available from:
    https://medlineplus.gov/druginfo/meds/a604004.html
  4. Emtricitabine – DrugBank [Internet]. Drugbank.ca. 2018 [cited 21 March 2018]. Available from:
    https://www.drugbank.ca/drugs/DB00879
  5. Tenofovir alafenamide – DrugBank [Internet]. Drugbank.ca. 2018 [cited 21 December 2018]. Available from:
    https://www.drugbank.ca/drugs/DB09299
  6. [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 21 December 2018]. Available from:
    https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=72e6b33c-0351-4070-9172-eeaa186c01d2

Substitutes for Kocitaf Tablet

Alafevir De Tablet

Spegra Tablet

Reviews (0)
0 ★
0 Ratings
5 ★
0
4 ★
0
3 ★
0
2 ★
0
1 ★
0

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Scroll To Top
Close
Close
Close

My Cart

Shopping cart is empty!

Continue Shopping

Open chat
Need Help?
Welcome to HIVHUB
Hello
Can we help you ?